Select the type of procedure
21534178
1
Enquiry period
with
29.12.2025 16:41
to 04.01.2026 11:58
to 04.01.2026 11:58
2
Bidding period
with
04.01.2026 11:58
to 08.01.2026 12:08
to 08.01.2026 12:08
3
Auction
09.01.2026 13:00
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
600 003,99 MDL
Period of clarifications:
29 Dec 2025, 16:41 - 4 Jan 2026, 11:58
Submission of proposals:
4 Jan 2026, 11:58 - 8 Jan 2026, 12:08
Supplier technical support:
(+373) 79999801
Subscribe impossible
during the period Evaluation
“Achiziționarea medicamentelor necesare pentru realizarea Programului Național de Transplant pentru anul 2026, repetat nr. 3”
Information about customer
Fiscal code/IDNO
Address
MD-2005, MOLDOVA, mun.Chişinău, locality, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2
Web site
---
The contact person
Purchase data
Date created
29 Dec 2025, 16:31
Date modified
2 Jan 2026, 11:58
Achizitii.md ID
21534178
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 2 - Filgrastimum 30 MUI sau 300 mcg
Budget: 1224.0 MDL
Purchase has not taken place
Lot nr. 3 - Methoxy polyethylene glycol-epoetin beta 50 mcg/0.3 ml
Budget: 183031.87 MDL
Purchase has not taken place
Documents of the procurement procedure
Scrisoare de garantie bancara_Model
Technical Specifications
Scrisoare de garantie bancara_Model
29.12.25 16:41
Documentatia standard Transplant rep 3.signed
Bidding Documents
Documentatia standard Transplant rep 3.signed
29.12.25 16:41
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
29.12.25 16:41
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
29.12.25 16:41
Anunt de participare Transplant rep 3.signed
Bidding Documents
Anunt de participare Transplant rep 3.signed
29.12.25 16:41
Anunt de participare 02.01.2026.signed
Bidding Documents
Anunt de participare 02.01.2026.signed
2.01.26 11:58
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK